Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Volume

Cytotech55,

Buy out?  Why all this misbegotten fear?  Poet’s management would be fools to accept a BO, if we’ve got the goods.  If we don’t have a disruptive product, if the Interposer is a plain vanilla solution, then management will go with a buy out.  That’s it for me. 

I'd like to put out this fire, because talking of a BO just seems sooo... extremely premature.  Everybody concerned over this issue should take a break from their screens.  TMI

Share
New Message
Please login to post a reply